Astronomers using ESO's New Technology Telescope have measured the distribution of mass inside a dark filament in a molecular cloud with an amazing level of detail and to great depth, based on a new method that looks at the scattered near-infrared light or 'cloudshine.'

Dark clouds are feebly illuminated by nearby stars. This light is scattered by the dust contained in the clouds, an effect dubbed 'cloudshine' by Harvard astronomers Alyssa Goodman and Jonathan Foster. This effect is well known to sky lovers, as they create in visible light wonderful pieces of art called 'reflection nebulae'. The Chameleon I complex nebula is one beautiful example.

The vast expanses between stars are permeated with giant complexes of cold gas and dust opaque to visible light.

Tests on a ‘virtual physiological human’ (VPH) have simulated how well an HIV drug blocks a key protein in the lethal virus, say scientists in the UK. The method could pave the way to personalized drug treatments, such as for HIV patients developing resistance to their current regimes.

The human body is too complex to replicate using a single computer or even several computers strapped together. To fully simulate our inner workings, the VPH has to link networks of computers nation- and worldwide. With all this power assembled, scientists can then carry out studies of "supercomputing" proportions, such as the effects of a drug at the organ, tissue, cell and even molecular levels.

A team of Penn State University researchers is the first to demonstrate that lipid molecules in cell membranes participate in mammals' reactions to allergens in a living cell. The finding will help scientists better understand how allergy symptoms are triggered, and could contribute to the creation of improved drugs to treat them.

The team studied clusters of cholesterol-rich lipid molecules that they believe serve as platforms for the receptors that receive antibodies, the proteins that protect the body from allergens. In this case, the team examined IgE antibodies, which upon binding to their receptors initiate a cell's release of histamine--the substance that causes the unpleasant, but beneficial, mucous production, congestion, and itchiness associated with allergies.

A new interactive website – www.darwin.rcuk.ac.uk - has been launched today that people the chance to learn about Darwin’s theories of evolution and what they mean today. It shows how his ideas are influencing our broader culture as well as science, engineering, and social science and invites people to join in discussions with researchers.

The website will:

•Survey what interests or puzzles people about evolution, which will help inform the development of our engagement activities
•Showcase the contemporary application of evolutionary theory
•Provide a forum for discussing questions about evolution

Next year will see nationwide celebrations to mark the 200th anniversary of Charles Darwin’s birth and the 150th anniversary of the publication of his groundbreaking book On the Origin of Species (and we'll be hosting our own series of articles, events and retrospectives at DarwinDay2009.com - editors).

Cannabis, the genus of flowering plants commonly known as marijuana, may create medicines that can help cure nicotine addiction, say University of Nottingham pharmacologists who have been studying the cannabis-like compounds which exist naturally in our bodies (endocannabinoids), and are exploring their potential for medical treatment. This includes treating conditions as diverse as obesity, diabetes, depression and addiction to substances like nicotine.

Scientists have known about endocannabinoids since the mid-1990s. This led to an explosion in the number of researchers looking into the future medical uses of cannabinoids and cannabis compounds.

Dr Steve Alexander, Associate Professor in the School of Biomedical Sciences, focused on a number of these projects in editing the first themed podcast for the British Journal of Pharmacology.

Only 45 percent of baseball players were able to return to the game at the same or higher level after shoulder or elbow surgery, according to new research released today during the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center.